RNF44 expression based on
PAAD : Pancreatic adenocarcinoma *
Please note that low number(<10) of normal samples considered.
Comparison Statistical significance Normal-vs-Primary 4.486200E-01
Pan-cancer view
Methylation
Survival
Correlated genes
DepMap
PAAD : Pancreatic adenocarcinoma *
Please note that low number(<10) of normal samples considered.
Note
Cancer stage information is not available for 3 samples.
Show statistics
Hide statistics
Comparison Statistical significance
Normal-vs-Stage1
4.470000E-01
Normal-vs-Stage2
4.629000E-01
Normal-vs-Stage3
2.013800E-01
Normal-vs-Stage4
4.049000E-01
Stage1-vs-Stage2
6.178800E-01
Stage1-vs-Stage3
1.102220E-01
Stage1-vs-Stage4
6.558400E-01
Stage2-vs-Stage3
9.163700E-02
Stage2-vs-Stage4
6.907800E-01
Stage3-vs-Stage4
2.077000E-01
Pan-cancer view
Methylation
Survival
Correlated genes
DepMap
PAAD : Pancreatic adenocarcinoma *
Please note that low number(<10) of normal samples considered.
Note
Patient race information is not available for 5 samples.
Show statistics
Hide statistics
Comparison Statistical significance
Normal-vs-Caucasian
4.476000E-01
Normal-vs-AfricanAmerican
3.735800E-01
Normal-vs-Asian
5.169800E-01
Caucasian-vs-AfricanAmerican
2.561200E-01
Caucasian-vs-Asian
4.823600E-01
AfricanAmerican-vs-Asian
1.263030E-01
Pan-cancer view
Methylation
Survival
Correlated genes
DepMap
PAAD : Pancreatic adenocarcinoma *
Please note that low number(<10) of normal samples considered.
Note
Patient gender information is not available for 1 sample.
Show statistics
Hide statistics
Comparison Statistical significance
Normal-vs-Male
4.632000E-01
Normal-vs-Female
4.326800E-01
Male-vs-Female
2.648400E-01
Pan-cancer view
Methylation
Survival
Correlated genes
DepMap
PAAD : Pancreatic adenocarcinoma *
Please note that low number(<10) of normal samples considered.
Note
Patient age information is not available for 1 sample.
Show statistics
Hide statistics
Comparison Statistical significance
Normal-vs-Age(21-40Yrs)
5.129000E-01
Normal-vs-Age(41-60Yrs)
4.929800E-01
Normal-vs-Age(61-80Yrs)
4.285600E-01
Normal-vs-Age(81-100Yrs)
4.290000E-01
Age(21-40Yrs)-vs-Age(41-60Yrs)
8.666200E-01
Age(21-40Yrs)-vs-Age(61-80Yrs)
4.915800E-01
Age(21-40Yrs)-vs-Age(81-100Yrs)
4.199800E-01
Age(41-60Yrs)-vs-Age(61-80Yrs)
3.894300E-02
Age(41-60Yrs)-vs-Age(81-100Yrs)
1.998040E-01
Age(61-80Yrs)-vs-Age(81-100Yrs)
9.789400E-01
Pan-cancer view
Methylation
Survival
Correlated genes
DepMap
PAAD : Pancreatic adenocarcinoma *
Please note that low number(<10) of normal samples considered.
Note
Drinking status is not available for 80 samples.
Show statistics
Hide statistics
Comparison Statistical significance
Normal-vs-Non Drinker
4.670200E-01
Normal-vs-Daily Drinker
4.515200E-01
Normal-vs-Weekly Drinker
4.165400E-01
Normal-vs-Occasional Drinker
4.687200E-01
Normal-vs-Social Drinker
4.851200E-01
Non Drinker-vs-Daily Drinker
8.039200E-01
Non Drinker-vs-Weekly Drinker
4.682800E-01
Non Drinker-vs-Occasional Drinker
9.745200E-01
Non Drinker-vs-Social Drinker
7.949000E-01
Daily Drinker-vs-Weekly Drinker
5.661200E-01
Daily Drinker-vs-Occasional Drinker
7.625200E-01
Daily Drinker-vs-Social Drinker
5.811400E-01
Weekly Drinker-vs-Occasional Drinker
4.098200E-01
Weekly Drinker-vs-Social Drinker
3.126800E-01
Occasional Drinker-vs-Social Drinker
7.863800E-01
Pan-cancer view
Methylation
Survival
Correlated genes
DepMap
PAAD : Pancreatic adenocarcinoma
Subtype descriptions Grade 1 Well differentiated (low grade)
Grade 2 Moderately differentiated (intermediate grade) Grade 3 Poorly differentiated (high grade)
Grade 4 Undifferentiated (high grade)
Show statistics
Hide statistics
Comparison Statistical significance
Normal-vs-Grade 1
6.639600E-02
Normal-vs-Grade 2
2.262900E-03
Normal-vs-Grade 3
1.815720E-03
Normal-vs-Grade 4
1.000000E+00
Grade 1-vs-Grade 2
1.671640E-02
Grade 1-vs-Grade 3
9.120400E-03
Grade 1-vs-Grade 4
6.639600E-02
Grade 2-vs-Grade 3
4.125800E-01
Grade 2-vs-Grade 4
2.262900E-03
Grade 3-vs-Grade 4
1.815720E-03
Pan-cancer view
Methylation
Survival
Correlated genes
DepMap
PAAD : Pancreatic adenocarcinoma *
Please note that low number(<10) of normal samples considered.
Note
Diabetes status information is not available for 30 samples.
Show statistics
Hide statistics
Comparison Statistical significance
Normal-vs-Diabetic
4.526200E-01
Normal-vs-NonDiabetic
4.508400E-01
Diabetic-vs-NonDiabetic
9.794000E-01
Pan-cancer view
Methylation
Survival
Correlated genes
DepMap
PAAD : Pancreatic adenocarcinoma *
Please note that low number(<10) of normal samples considered.
Note
Pancreatitis status is not available for 39 samples.
Show statistics
Hide statistics
Comparison Statistical significance
Normal-vs-Pancreatitis
5.055000E-01
Normal-vs-NoPancreatitis
4.497800E-01
Pancreatitis-vs-NoPancreatitis
3.592400E-01
Pan-cancer view
Methylation
Survival
Correlated genes
DepMap
PAAD : Pancreatic adenocarcinoma *
Please note that low number(<10) of normal samples considered.
Note
Nodal metastais status is not available for 1 sample and cancer in nearby lymph nodes cannot be measured (NX) in 4 samples.
pathologic_N descriptions N0 No regional lymph node metastasis
N1 Metastases in 1 to 3 axillary lymph nodes N2 Metastases in 4 to 9 axillary lymph nodes
N3 Metastases in 10 or more axillary lymph nodes
Show statistics
Hide statistics
Comparison Statistical significance
Normal-vs-N0
4.504400E-01
Normal-vs-N1
4.471800E-01
N0-vs-N1
9.257600E-01
Pan-cancer view
Methylation
Survival
Correlated genes
DepMap
PAAD : Pancreatic adenocarcinoma *
Please note that low number(<10) of normal samples considered.
Note
Whole exome sequencing data is not available for 3 samples.
TP53 mutation status is obtained from TCGA whole exome sequencing data. We downloaded Mutation Annotation Format (MAF) files (derived from VarScan2) from Genomic Data Commons portal. The sample with/without TP53 mutation were matched with RNA-seq data
Show statistics
Hide statistics
Comparison Statistical significance
Normal-vs-TP53-Mutant
5.207200E-01
Normal-vs-TP53-NonMutant
4.438400E-01
TP53-Mutant-vs-TP53-NonMutant
6.966000E-02
Pan-cancer view
Methylation
Survival
Correlated genes
DepMap
